- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Ophthalmology MDTV
WHO Issues Safety Over Rare Eye Disorder from Semaglutide Use
WHO is alerting health-care professionals and regulatory authorities to the risk of non-arteritic anterior ischemic...
Diabetes and Weight-Loss Drug Semaglutide Linked to Rare Eye...
The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of...
Fear of Vision Loss May Delay Cataract Surgery: Study Finds
Fear of vision loss may deter some patients from undergoing necessary cataract surgery, according to a newly published...
BRESER Study Demonstrates Real-World Efficacy and Safety of Lupin's...
Ranieyes is the Ranibizumab Biosimilar which is an Indian Ranibizumab Biosimilar manufactured by Lupin Ltd &...
Screen Time Surge: Digital Devices Linked to Rising Nearsightedness,...
The association of digital screen time with myopia has been documented, but the dose-response association and safe...
Pioneering Retinal-Surgery Robot from University of Utah Shows Early...
When even the most highly trained surgeons perform procedures on the retina-one of the smallest, most delicate parts of...
Genetic Breakthrough Restores Vision: Infants Gain New Sight, Study...
Four young children have gained life-changing improvements in sight following treatment with a pioneering new genetic...
New Research Highlights Effective Stem Cell Treatment for Inflammatory...
In a new study, researchers have proposed a novel therapy for ocular Graft-versus-host disease involving Mesenchymal...
New Eye Drop Therapy For Dry Age Related Macular Degeneration: Study...
The research team from the Natural Product Drug Development Center at the Korea Institute of Science and Technology has...
Safety of Lupin's Ranibizumab (Ranieyes) established in Large-Scale...
Real-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab...
Journal Club-Systematic review of surgical techniques for treating...
Giant retinal tears (GRTs) are rare and challenging complications of rhegmatogenous retinal detachment (RRD) that...
Improving Eye Health? Eat Pistachios: Researchers Reveal
A new study from researchers at the Friedman School of Nutrition Science and Policy at Tufts University has found that...